The Board of Suga International Holdings Limited announced that Dr. Law Sui Chun has been appointed as an independent non-executive director of the Company and a member each of the audit committee, the remuneration committee and the nomination committee of the Company with effect from 1 October 2023. Dr. Law Sui Chun, aged 51, holds a PhD in Chemistry specializing in Nano & Advanced Materials synthesis and an MPhil in Chemistry focusing on Polymer and Materials Science for Micro-Electronics Fabrication from the Hong Kong University of Science and Technology. Dr. Law is the Deputy Chairman, Activities & Events Sub-com Chairman and Innovation & Technology Sub- com Chairman of The Hong Kong Electronic and Technologies Associations, a board director and technology expert at the Nano and Advanced Materials Institute Ltd. (NAMI).

She also serves as a panel member for Technology Expertise at the Logistics and Supply Chain MultiTech R&D Centre and the Committee member on Innovation, Technology, and Re-industrialization for the Innovation, Technology, and Industry Bureau. Dr. Law served as an Executive Member of the Training and Education Panel at The Hong Kong Medical and Healthcare Device Industries Association from 2018 to 2020 and contributed to the Appeal Board Panel (Town Planning) under the government of Hong Kong Special Administrative Region (HKSAR) from 2012 to 2018. Her active engagement in pivotal governmental initiatives and innovation schemes is evident through her participation in vetting committees and panel assessments, notably for Small Entrepreneur Research Assistance Programme (SERAP) from 2009 to 2015, Enterprise Support Scheme (ESS) from 2015 to 2021, and as the member of Assessment Panel of the Innovation and Technology Fund Better Living from 2018 to 2023.

Dr. Law has not held any directorship in any listed company in the past three years or any position with the Company and any other members of the Company's group. The Company will enter into an appointment letter with Dr. Law for a term of one year commencing on 1 October 2023. Dr. Law is also subject to retirement and re-election at the next annual general meeting following her appointment and thereafter is subject to retirement by rotation and re-election at the annual general meeting of the Company in accordance with the bye-laws of the Company.

The Board also announced that due to his desire to devote more time to his personal affairs, Dr. Cheung Nim Kwan has resigned as an independent non-executive director and a member of the audit committee, the remuneration committee and the nomination committee of the Company with effect from 15 October 2023.